Reval has appointed Steve Rosenberg to its board of directors. Rosenberg is senior vice president of Phase Forward, a provider of data management solutions for clinical trials and drug safety. At Phase Forward, Rosenberg oversees product development, product management, the North American services organisation and the company’s worldwide production hosting operation. Rosenberg has over 27 years experience in the software industry. Prior to Phase Forward, he served as the senior vice president of development and client services at W3 Health, where he led the development and implementation of the company’s flagship healthcare analytics ASP environment, and participated in venture capital activities and sales campaigns. In addition to his professional work, Rosenberg currently serves as chairman of the board of trustees for St. Ann’s Home, a school and residential facility for disturbed and abused children.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.